Global Microbiomes Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Microbiomes Revenue
• 1.4 Market by Type
  • 1.4.1 Global Microbiomes Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Gastrointestinal Microbiome
  • 1.4.3 Genitourinary Microbiome
  • 1.4.4 Skin Microbiome
  • 1.4.5 Respiratory Microbiome
  • 1.4.6 Other
• 1.5 Market by Application
  • 1.5.1 Global Microbiomes Market Share by Application: 2020 VS 2026
  • 1.5.2 Testing
  • 1.5.3 Treatment
  • 1.5.4 Diagnosis
  • 1.5.5 Technology Platform
  • 1.5.6 Probiotics
  • 1.5.7 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Microbiomes Market Perspective (2015-2026)
• 2.2 Global Microbiomes Growth Trends by Regions
  • 2.2.1 Microbiomes Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Microbiomes Historic Market Share by Regions (2015-2020)
  • 2.2.3 Microbiomes Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Microbiomes Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Microbiomes Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Microbiomes Players by Market Size
  • 3.1.1 Global Top Microbiomes Players by Revenue (2015-2020)
  • 3.1.2 Global Microbiomes Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Microbiomes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Microbiomes Market Concentration Ratio
  • 3.2.1 Global Microbiomes Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Microbiomes Revenue in 2019
• 3.3 Microbiomes Key Players Head office and Area Served
• 3.4 Key Players Microbiomes Product Solution and Service
• 3.5 Date of Enter into Microbiomes Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Microbiomes Historic Market Size by Type (2015-2020)
• 4.2 Global Microbiomes Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Microbiomes Market Size by Application (2015-2020)
• 5.2 Global Microbiomes Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Microbiomes Market Size (2015-2020)
• 6.2 Microbiomes Key Players in North America (2019-2020)
• 6.3 North America Microbiomes Market Size by Type (2015-2020)
• 6.4 North America Microbiomes Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Microbiomes Market Size (2015-2020)
• 7.2 Microbiomes Key Players in Europe (2019-2020)
• 7.3 Europe Microbiomes Market Size by Type (2015-2020)
• 7.4 Europe Microbiomes Market Size by Application (2015-2020)

8 China

• 8.1 China Microbiomes Market Size (2015-2020)
• 8.2 Microbiomes Key Players in China (2019-2020)
• 8.3 China Microbiomes Market Size by Type (2015-2020)
• 8.4 China Microbiomes Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Microbiomes Market Size (2015-2020)
• 9.2 Microbiomes Key Players in Japan (2019-2020)
• 9.3 Japan Microbiomes Market Size by Type (2015-2020)
• 9.4 Japan Microbiomes Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Microbiomes Market Size (2015-2020)
• 10.2 Microbiomes Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Microbiomes Market Size by Type (2015-2020)
• 10.4 Southeast Asia Microbiomes Market Size by Application (2015-2020)

11 India

• 11.1 India Microbiomes Market Size (2015-2020)
• 11.2 Microbiomes Key Players in India (2019-2020)
• 11.3 India Microbiomes Market Size by Type (2015-2020)
• 11.4 India Microbiomes Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Microbiomes Market Size (2015-2020)
• 12.2 Microbiomes Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Microbiomes Market Size by Type (2015-2020)
• 12.4 Central & South America Microbiomes Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 4D Pharma
  • 13.1.1 4D Pharma Company Details
  • 13.1.2 4D Pharma Business Overview
  • 13.1.3 4D Pharma Microbiomes Introduction
  • 13.1.4 4D Pharma Revenue in Microbiomes Business (2015-2020))
  • 13.1.5 4D Pharma Recent Development
• 13.2 Enterome BioScience
  • 13.2.1 Enterome BioScience Company Details
  • 13.2.2 Enterome BioScience Business Overview
  • 13.2.3 Enterome BioScience Microbiomes Introduction
  • 13.2.4 Enterome BioScience Revenue in Microbiomes Business (2015-2020)
  • 13.2.5 Enterome BioScience Recent Development
• 13.3 Evelo Biosciences
  • 13.3.1 Evelo Biosciences Company Details
  • 13.3.2 Evelo Biosciences Business Overview
  • 13.3.3 Evelo Biosciences Microbiomes Introduction
  • 13.3.4 Evelo Biosciences Revenue in Microbiomes Business (2015-2020)
  • 13.3.5 Evelo Biosciences Recent Development
• 13.4 Ferring
  • 13.4.1 Ferring Company Details
  • 13.4.2 Ferring Business Overview
  • 13.4.3 Ferring Microbiomes Introduction
  • 13.4.4 Ferring Revenue in Microbiomes Business (2015-2020)
  • 13.4.5 Ferring Recent Development
• 13.5 Osel
  • 13.5.1 Osel Company Details
  • 13.5.2 Osel Business Overview
  • 13.5.3 Osel Microbiomes Introduction
  • 13.5.4 Osel Revenue in Microbiomes Business (2015-2020)
  • 13.5.5 Osel Recent Development
• 13.6 Second Genome
  • 13.6.1 Second Genome Company Details
  • 13.6.2 Second Genome Business Overview
  • 13.6.3 Second Genome Microbiomes Introduction
  • 13.6.4 Second Genome Revenue in Microbiomes Business (2015-2020)
  • 13.6.5 Second Genome Recent Development
• 13.7 Seres Therapeutics
  • 13.7.1 Seres Therapeutics Company Details
  • 13.7.2 Seres Therapeutics Business Overview
  • 13.7.3 Seres Therapeutics Microbiomes Introduction
  • 13.7.4 Seres Therapeutics Revenue in Microbiomes Business (2015-2020)
  • 13.7.5 Seres Therapeutics Recent Development
• 13.8 Synlogic
  • 13.8.1 Synlogic Company Details
  • 13.8.2 Synlogic Business Overview
  • 13.8.3 Synlogic Microbiomes Introduction
  • 13.8.4 Synlogic Revenue in Microbiomes Business (2015-2020)
  • 13.8.5 Synlogic Recent Development
• 13.9 Synthetic Biologics and Vedanta Biosciences
  • 13.9.1 Synthetic Biologics and Vedanta Biosciences Company Details
  • 13.9.2 Synthetic Biologics and Vedanta Biosciences Business Overview
  • 13.9.3 Synthetic Biologics and Vedanta Biosciences Microbiomes Introduction
  • 13.9.4 Synthetic Biologics and Vedanta Biosciences Revenue in Microbiomes Business (2015-2020)
  • 13.9.5 Synthetic Biologics and Vedanta Biosciences Recent Development
• 13.10 Vedanta
  • 13.10.1 Vedanta Company Details
  • 13.10.2 Vedanta Business Overview
  • 13.10.3 Vedanta Microbiomes Introduction
  • 13.10.4 Vedanta Revenue in Microbiomes Business (2015-2020)
  • 13.10.5 Vedanta Recent Development
• 13.11 Rebiotix
  • 10.11.1 Rebiotix Company Details
  • 10.11.2 Rebiotix Business Overview
  • 10.11.3 Rebiotix Microbiomes Introduction
  • 10.11.4 Rebiotix Revenue in Microbiomes Business (2015-2020)
  • 10.11.5 Rebiotix Recent Development
• 13.12 ActoGeniX
  • 10.12.1 ActoGeniX Company Details
  • 10.12.2 ActoGeniX Business Overview
  • 10.12.3 ActoGeniX Microbiomes Introduction
  • 10.12.4 ActoGeniX Revenue in Microbiomes Business (2015-2020)
  • 10.12.5 ActoGeniX Recent Development
• 13.13 Enterologics
  • 10.13.1 Enterologics Company Details
  • 10.13.2 Enterologics Business Overview
  • 10.13.3 Enterologics Microbiomes Introduction
  • 10.13.4 Enterologics Revenue in Microbiomes Business (2015-2020)
  • 10.13.5 Enterologics Recent Development
• 13.14 Metabogen
  • 10.14.1 Metabogen Company Details
  • 10.14.2 Metabogen Business Overview
  • 10.14.3 Metabogen Microbiomes Introduction
  • 10.14.4 Metabogen Revenue in Microbiomes Business (2015-2020)
  • 10.14.5 Metabogen Recent Development
• 13.15 Metabiomics
  • 10.15.1 Metabiomics Company Details
  • 10.15.2 Metabiomics Business Overview
  • 10.15.3 Metabiomics Microbiomes Introduction
  • 10.15.4 Metabiomics Revenue in Microbiomes Business (2015-2020)
  • 10.15.5 Metabiomics Recent Development
• 13.16 Ritter Pharmaceuticals
  • 10.16.1 Ritter Pharmaceuticals Company Details
  • 10.16.2 Ritter Pharmaceuticals Business Overview
  • 10.16.3 Ritter Pharmaceuticals Microbiomes Introduction
  • 10.16.4 Ritter Pharmaceuticals Revenue in Microbiomes Business (2015-2020)
  • 10.16.5 Ritter Pharmaceuticals Recent Development
• 13.17 AvidBiotics
  • 10.17.1 AvidBiotics Company Details
  • 10.17.2 AvidBiotics Business Overview
  • 10.17.3 AvidBiotics Microbiomes Introduction
  • 10.17.4 AvidBiotics Revenue in Microbiomes Business (2015-2020)
  • 10.17.5 AvidBiotics Recent Development
• 13.18 Symberix
  • 10.18.1 Symberix Company Details
  • 10.18.2 Symberix Business Overview
  • 10.18.3 Symberix Microbiomes Introduction
  • 10.18.4 Symberix Revenue in Microbiomes Business (2015-2020)
  • 10.18.5 Symberix Recent Development
• 13.19 Miomics
  • 10.19.1 Miomics Company Details
  • 10.19.2 Miomics Business Overview
  • 10.19.3 Miomics Microbiomes Introduction
  • 10.19.4 Miomics Revenue in Microbiomes Business (2015-2020)
  • 10.19.5 Miomics Recent Development
• 13.20 Symbiotix Biotherapies
  • 10.20.1 Symbiotix Biotherapies Company Details
  • 10.20.2 Symbiotix Biotherapies Business Overview
  • 10.20.3 Symbiotix Biotherapies Microbiomes Introduction
  • 10.20.4 Symbiotix Biotherapies Revenue in Microbiomes Business (2015-2020)
  • 10.20.5 Symbiotix Biotherapies Recent Development
• 13.21 MicroBiome Therapeutics LLC
  • 10.21.1 MicroBiome Therapeutics LLC Company Details
  • 10.21.2 MicroBiome Therapeutics LLC Business Overview
  • 10.21.3 MicroBiome Therapeutics LLC Microbiomes Introduction
  • 10.21.4 MicroBiome Therapeutics LLC Revenue in Microbiomes Business (2015-2020)
  • 10.21.5 MicroBiome Therapeutics LLC Recent Development
• 13.22 SciBac Inc
  • 10.22.1 SciBac Inc Company Details
  • 10.22.2 SciBac Inc Business Overview
  • 10.22.3 SciBac Inc Microbiomes Introduction
  • 10.22.4 SciBac Inc Revenue in Microbiomes Business (2015-2020)
  • 10.22.5 SciBac Inc Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer